LOXL2 and diabetes mellitus: A logistic regression model including time since transplantation, IFTA, hypertension/diabetes status (HTN/DM), and mean LOXL2+ cells in the biopsy was applied in non rejection biopsies to predict a 0.5 mg/dl increase of the baseline creatinine (11).